Avillion II (AZ) Revenue and Competitors
Estimated Revenue & Valuation
- Avillion II (AZ)'s estimated annual revenue is currently $6.2M per year.
- Avillion II (AZ)'s estimated revenue per employee is $201,000
Employee Data
- Avillion II (AZ) has 31 Employees.
- Avillion II (AZ) grew their employee count by -11% last year.
Avillion II (AZ)'s People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Chief Commercial Officer | Reveal Email/Phone |
3 | VP Clinical Development | Reveal Email/Phone |
4 | Director Regulatory Affairs | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Senior Director, Clinical Programs | Reveal Email/Phone |
8 | Operations Director | Reveal Email/Phone |
9 | Project Manager | Reveal Email/Phone |
10 | FP&A Manager | Reveal Email/Phone |
Avillion II (AZ) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is Avillion II (AZ)?
A drug development company with an innovative model for Clinical Development. We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.
keywords:N/AN/A
Total Funding
31
Number of Employees
$6.2M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.3M | 31 | -6% | N/A |
#2 | $3.6M | 31 | 0% | N/A |
#3 | $3.6M | 31 | -55% | N/A |
#4 | $2.5M | 31 | -40% | N/A |
#5 | $4.1M | 31 | -14% | N/A |